Antiplatelet and anticoagulant drugs management before gastrointestinal endoscopy: Do clinicians adhere to current guidelines?. Issue 1 (January 2015)
- Record Type:
- Journal Article
- Title:
- Antiplatelet and anticoagulant drugs management before gastrointestinal endoscopy: Do clinicians adhere to current guidelines?. Issue 1 (January 2015)
- Main Title:
- Antiplatelet and anticoagulant drugs management before gastrointestinal endoscopy: Do clinicians adhere to current guidelines?
- Authors:
- Bruno, Mauro
Marengo, Andrea
Elia, Chiara
Caronna, Stefania
Debernardi-Venon, Wilma
Manfrè, Selene Francesca
Musso, Alessandro
Puglisi, Flavia
Sguazzini, Carlo
Rizzetto, Mario
De Angelis, Claudio - Abstract:
- <abstract abstract-type="author" id="abs0005"> <title id="sect0005">Abstract</title> <sec> <title id="sect0010">Background</title> <p id="spar0005">Managing antiplatelet and anticoagulant drugs before endoscopy may be challenging.</p> </sec> <sec> <title id="sect0015">Aims</title> <p id="spar0010">To assess whether the pre-endoscopic management of antiplatelet/anticoagulant drugs is adherent to current guidelines and the influence of patients' characteristics, referring physician's specialty, type of endoscopic procedure and therapeutic regimen on adherence.</p> </sec> <sec> <title id="sect0020">Methods</title> <p id="spar0015">Two hundred and twenty patients taking aspirin, thienopyridines or warfarin and scheduled for upper endoscopy (± biopsies), variceal band ligation, colonoscopy (± biopsies or polypectomy), were prospectively analyzed.</p> </sec> <sec> <title id="sect0025">Results</title> <p id="spar0020">In 109 patients (49.5%) the management of antiplatelet/anticoagulant drugs was thoroughly compliant with guidelines. Neither demographic characteristics, nor in/outpatient status, nor type of endoscopic procedure, nor physician's specialty influenced the adherence but the therapeutic regimen had a significant impact (<italic>p</italic> &lt; 0.0001) as compliance was less likely in patients on warfarin. Unwarranted drugs withholding was more frequent before colonoscopy than upper endoscopy (<italic>p</italic> = 0.0001). Warfarin was stopped longer than recommended more<abstract abstract-type="author" id="abs0005"> <title id="sect0005">Abstract</title> <sec> <title id="sect0010">Background</title> <p id="spar0005">Managing antiplatelet and anticoagulant drugs before endoscopy may be challenging.</p> </sec> <sec> <title id="sect0015">Aims</title> <p id="spar0010">To assess whether the pre-endoscopic management of antiplatelet/anticoagulant drugs is adherent to current guidelines and the influence of patients' characteristics, referring physician's specialty, type of endoscopic procedure and therapeutic regimen on adherence.</p> </sec> <sec> <title id="sect0020">Methods</title> <p id="spar0015">Two hundred and twenty patients taking aspirin, thienopyridines or warfarin and scheduled for upper endoscopy (± biopsies), variceal band ligation, colonoscopy (± biopsies or polypectomy), were prospectively analyzed.</p> </sec> <sec> <title id="sect0025">Results</title> <p id="spar0020">In 109 patients (49.5%) the management of antiplatelet/anticoagulant drugs was thoroughly compliant with guidelines. Neither demographic characteristics, nor in/outpatient status, nor type of endoscopic procedure, nor physician's specialty influenced the adherence but the therapeutic regimen had a significant impact (<italic>p</italic> &lt; 0.0001) as compliance was less likely in patients on warfarin. Unwarranted drugs withholding was more frequent before colonoscopy than upper endoscopy (<italic>p</italic> = 0.0001). Warfarin was stopped longer than recommended more frequently than aspirin (<italic>p</italic> = 0.009). The International Normalized Ratio was properly checked before endoscopy in 47.7% of patients. Among the 55 patients who withheld warfarin, the decision about bridging to low molecular weight heparin was appropriate in 21 (38.2%).</p> </sec> <sec> <title id="sect0030">Conclusions</title> <p id="spar0025">Compliance with guidelines is low especially in the management of warfarin, both among gastroenterologists and other physicians.</p> </sec> </abstract> … (more)
- Is Part Of:
- Digestive and liver disease. Volume 47:Issue 1(2015)
- Journal:
- Digestive and liver disease
- Issue:
- Volume 47:Issue 1(2015)
- Issue Display:
- Volume 47, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 47
- Issue:
- 1
- Issue Sort Value:
- 2015-0047-0001-0000
- Page Start:
- 45
- Page End:
- 49
- Publication Date:
- 2015-01
- Subjects:
- Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.dld.2014.10.017 ↗
- Languages:
- English
- ISSNs:
- 1590-8658
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3922.xml